This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rommens, J.M. et al. Science 245, 1059–1065 (1989).
Riordan, J.R. et al. Science 245, 1066–1073 (1989).
Kerem, B. et al. Science 245, 1073–1080 (1989).
Sampson, H.M. et al. Chem. Biol. 18, 231–242 (2011).
Hutt, D.M. et al. Nat. Chem. Biol. 6, 25–33 (2010).
Rights and permissions
About this article
Cite this article
Dolgin, E. Mutation-specific cystic fibrosis treatments on verge of approval. Nat Med 17, 396–397 (2011). https://doi.org/10.1038/nm0411-396
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0411-396
This article is cited by
-
Exon-skipping drug pulls ahead in muscular dystrophy field
Nature Medicine (2012)
-
Erwachsene mit Mukoviszidose
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2012)